For chronic pain sufferers, there is a real problem with the abuse of painkillers in the United States. While the number of patients who have a legitimate need for prescription painkillers — 100 million plus — is vastly more than the number of people addicted to painkillers — 11 million — there is a stigma attached to the prescribing, dispensing and utilization of pain medicines.
The pharmaceutical company is donating thousands of its Evzio auto-injectors ahead of a planned Oct. 4 Washington, D.C. rally for recognizing and treating opioid addiction.
CVS/pharmacy has also renewed its Medication Disposal for Safer Communities Program.
The Centers for Disease Control and prevention this week announced that a new draft guideline for prescribing opioids to patients with chronic pain was in the works.
PUTTING A FACE ON PAIN MANAGEMENT
Chronic pain sufferer Dennis Kinch pens book to encourage pain community
Ehlers-Danlos Syndrome patient Ellen Smith serves as advocate for pain relief
Gina Libby strives to improve pain medication legislation
Former radio personality Radene Marie Cook rues 'fail first' treatment plans
U.S. Pain Foundation founder and president Paul Gileno duscusses his personal connection to chronic pain and the importance of focusing on pain management — particularly during September, Pain Awareness Month.
However, patients in the 10-17 years age group also showed the greatest improvement in appropriate prescription drug use compared to all other age groups over a four-year period.
The Centers for Disease Control and Prevention has launced its new program, “Prescription Drug Overdose: Prevention for States,” which aims to invest in 16 states currently battling an epidemic of prescription drug overdoses.
The program asks individuals living with pain and providers to design the ideal experience in the exam room that would foster dialogue about prescription drug abuse, deterrent technology and the effect of pain.
The website includes sections about the importance of preventing abuse of prescription drugs and outlines the Food and Drug Administrations guidelines on abuse-deterrent labeling.
Quell utilizes NeuroMetrix's proprietary non-invasive neurostimulation technology to provide relief from chronic pain, such as due to diabetes, sciatica, fibromyalgia and degenerative knee conditions.